Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors
about
Reconstitution of an infectious human endogenous retrovirusInteraction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencingAPOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1Broad-spectrum inhibition of retroviral and filoviral particle release by tetherinAPOBEC3G targets human T-cell leukemia virus type 1.APOBEC3G & HTLV-1: inhibition without deaminationHTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZMolecular Mechanisms of HTLV-1 Cell-to-Cell TransmissionModes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and PersistenceHuman T-lymphotropic virus-1 visualized at the virological synapse by electron tomographyStudies on the restriction of murine leukemia viruses by mouse APOBEC3Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted TherapyHuman T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.Current concepts regarding the HTLV-1 receptor complex.Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectorsC-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle releaseA novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.Integrase inhibitors effective against human T-cell leukemia virus type 1Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 GagGem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission.The role of ITCH protein in human T-cell leukemia virus type 1 release.Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytesResistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsidInteraction of human tumor viruses with host cell surface receptors and cell entryRole of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infectionHuman T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.Cellular Factors Involved in HTLV-1 Entry and PathogenicitImprovement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNAThe role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1).HTLV-1 tropism and envelope receptor.Reporter Systems to Study HTLV-1 Transmission.B'-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase.Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus EnvInteractions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle
P2860
Q21559512-633A7948-E865-4B7B-8C99-8565359E2442Q24300900-65592435-D7CD-42F3-A9B9-4F6D35DB78B3Q24310242-0AA63E0A-3E43-4320-AE2F-E6B4BD806A5EQ24318564-586A52F6-AEAE-4FAE-84CE-A3AA94855330Q24811566-D4874118-49BC-4A66-99C7-D5451536E552Q24811603-841AC558-EB2F-4B30-8F51-5EB4E84580E5Q26744330-DE4723AE-E084-43FE-A1E3-5EF60D6519F5Q26752562-675332B8-96A9-4D80-B594-6D1BFECE3895Q26801294-2C3FEA3D-B716-46A9-9985-5169EFDE7EC9Q27301309-BC76972E-5997-45F8-B45F-56628D8E6FACQ28729128-7E74DDBC-0A3F-45BA-BA22-486BC3D7044AQ28972318-0A591C5A-14E8-4B35-AFE2-B11B175E587EQ30497545-454F3B7D-C134-4E8B-B313-CFC5D5B22EB1Q33350169-8CC0D6B0-B8AD-499D-BB60-C57100A18B7EQ33535838-17A0497C-30AD-4748-8D1E-33C12B22F9E0Q33581258-DC649809-E3E0-4B11-96BB-15DB61F6CE92Q33966652-4CA28616-9F98-4AA7-B857-C48D3F14F204Q34185793-CACDCFAF-C205-4648-87D4-D165B5F6FDF2Q34353702-1A7AF39E-48BF-4772-BC76-7FBB49A59C22Q34932350-0D257FC1-3930-4703-8980-689B3D9FAF93Q35065987-B554177C-D704-4B87-A51C-2F534C55072AQ35076588-C221DA6A-0125-421D-BD94-30A8E6DE6C03Q35105616-7D2A7FB1-CF5D-45B6-914C-71B2EF9A584CQ35213144-0D42B62A-083B-4E7E-BB24-10E1FF26F0FEQ35634291-EC75AD0C-0B4A-4E76-B5A8-8E4EB8BB0F75Q35669808-E903ABE0-A889-4D34-9E23-F2E1E14B336DQ35676027-94D3098C-924E-45FE-9293-3A5959E35E48Q35826108-40C72A76-0DE0-4EAD-ADD7-0971BCA2C29CQ35857184-FFC06348-B51D-4AE2-BBC5-A1860EE17BB2Q35857436-B8C5B44C-88A1-4720-ADAB-9BBBA38AF997Q36049779-97A38CAF-3A4D-4892-9709-33D9CE95680FQ36086361-19A10366-9394-4868-BBFD-C19B55E38D9EQ36098938-73475BF8-E9BB-461D-B6A4-6AA8A118E4BEQ36173231-5B08BE7D-133D-4396-9429-829B57A1284FQ36254884-C9E8BDFA-C9C3-4F75-9630-00BBE4BF9A7CQ36327758-C76348D5-6FD9-4F24-B5B0-3183963F2B2EQ36443322-3F6DBC8C-7650-4889-B6D8-F9F6026E76FFQ36747774-8F996463-EECC-4D89-935E-9599B9E42C62Q36748014-F95134C2-B5B7-42BD-AB49-DDA929A074A3Q36845774-C8173BB9-1522-46FB-B0CB-84721EBCF5FB
P2860
Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Examining human T-lymphotropic ...... with recombinant virus vectors
@ast
Examining human T-lymphotropic ...... with recombinant virus vectors
@en
type
label
Examining human T-lymphotropic ...... with recombinant virus vectors
@ast
Examining human T-lymphotropic ...... with recombinant virus vectors
@en
prefLabel
Examining human T-lymphotropic ...... with recombinant virus vectors
@ast
Examining human T-lymphotropic ...... with recombinant virus vectors
@en
P2093
P2860
P1433
P1476
Examining human T-lymphotropic ...... with recombinant virus vectors
@en
P2093
P2860
P304
P356
10.1128/JVI.75.18.8461-8468.2001
P577
2001-09-01T00:00:00Z